Search Results

Dixon Technologies has issued an irrevocable corporate guarantee of 220 million USD on behalf of its subsidiary Padget Electronics in favor of Lenovo Ireland to secure IT hardware component procurement.

Recent CSO trade data reveals a sharp contraction in Irish medical and pharmaceutical exports for early 2026, marking a natural correction after an unprecedented period of tariff-preemptive stockpiling by multinational drug makers in 2025.

20 trophies presented at gala Dublin ceremony celebrating leadership, innovation, and clinical trials excellence across Ireland's €100B+ pharmaceutical and life sciences sector.

MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.

OpenAI secures an 88,000 sq ft lease at IPUT's iconic Tropical Fruit Warehouse on Sir John Rogerson's Quay, bringing 250 new high-tech jobs to Dublin as it expands its European headquarters.

A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.

As the Turnberry Deal’s 15% tariff baseline takes hold, Brussels has formally requested carve-outs for €150 billion worth of European goods. The stakes are exceptionally high for Ireland’s €13B medical technology industry, where critical components face severe transatlantic margin pressures.

Ireland’s goods exports fell by 29.1% to €16.5 billion in May 2026, driven by a €8 billion drop in pharmaceutical shipments, while imports rose 17.5% to €13.1 billion, narrowing the trade surplus.

Dublin-based Pilot Photonics receives up to €10.4 million in EIC Accelerator funding to scale high-volume manufacturing of its patented photonic integrated circuits (PICs) for AI data centres, satellite transceivers, and 6G networks.

Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.

Two promising Irish startups, prediction market trading assistant Blueprints and AI benchtop X-ray hardware builder ProvenMetal, have been accepted into the prestigious Y Combinator Summer 2026 cohort in San Francisco, securing $500,000 in seed backing each.

Dublin-based medical device developer CroíValve has secured a $27 million expansion of its Series B round, combining equity funding led by BGF and state grants to accelerate US and EU clinical trials for its DUO Adapt System.

Launched in Dundalk, the three-year Public Health Knowledge Hub (PHKH) project brings together the Institute of Public Health, Trinity College Dublin, and Ulster University to build the first-ever harmonised cross-border public health data portal.

Helus Pharma announces a $50 million offering to progress Phase 3 trials for their novel serotonergic agonists, alongside major clinical milestones and leadership updates.

An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.

A positive look at the June 2026 Fiscal Assessment Report, highlighting Ireland's strategic investments, robust corporate tax windfalls, and bold plans for infrastructure and savings funds.

The Irish Government, led by Minister James Lawless, has announced a historic €460 million investment to establish seven new national research and innovation hubs across critical sectors like AI, Pharma, and Quantum Science.

AI for Care The Artificial Intelligence (AI) Strategy for Healthcare in Ireland 2026-2030 AI Strategy for Healthcare Signals a New Era for Life Sciences